Is MDMA legal in United Arab Emirates?

Also known as: molly, ecstasy

Legal status

Midomafetamine is placed in Schedule 5 of Decision No. 158 of 2025 at the printed entry «MDMA؛ ميثيلين ديوكسي ميثامفيتامين», which carries the abbreviation together with the Arabic methylenedioxy methamphetamine description. The placement is in the first psychotropic schedule, not in the Schedule 6 branch that carries the plain methamphetamine entry, so the methylenedioxy compound and the parent stimulant are on different articles in this instrument despite the shared name fragment. Anyone reasoning from the word methamphetamine in the entry to the methamphetamine row's treatment would land on the wrong article. The row runs through Articles 10, 41 and 57, with Schedule 10 carrying the quantity bands. The placement was read on 20 September 2026.

Consequences if caught

Schedule 5 is one of the four schedule groups Article 57 names, and this entry is in Schedule 5, so the row carries the mandatory death formulation rather than the death or life alternative that Article 58 gives the Schedule 6 to 8 group. The dossier records Article 57 as stating no quantity for its trafficking or promotion trigger, and records that the Schedule 10 bands do not gate the route. A tablet count is therefore not the variable it would be in most jurisdictions, because the article that carries the capital exposure contains no count at all. Article 41 carries the personal use route for this branch, with its tariff unstated in the dossier.

If prescribed or medical

The dossier records at the modafinil row that a 268 entry ministry travellers list was checked and expressly not used as a schedule. Attached to this substance: the Schedule 5 placement at «MDMA؛ ميثيلين ديوكسي ميثامفيتامين», with no medicinal product, trial authorisation or prescribing route recorded against it. Therapeutic programmes for this compound exist in other jurisdictions and the dossier records nothing extending them here, so the question is deferred rather than inferred.

Documentation

No documentation route is recorded for this substance, and participation in a trial or programme elsewhere is not an Emirati authorisation on this record. Provenance: the Schedule 5 placement and the entry «MDMA؛ ميثيلين ديوكسي ميثامفيتامين» were read on 20 September 2026, with the capital analysis resting on Article 57 and not on the Schedule 10 bands. The point worth carrying is the schedule split: this compound is Schedule 5 and Article 57, while the parent stimulant it is named after is Schedule 6 and Article 58.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with United Arab Emirates’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.